In contrast to αβ T cells, γδ T cells recognize tumor cells not on the basis of tumor-specific antigenic peptides presented in the context of MHC class I or class II molecules but rather sense cell-surface-expressed stress molecules and/or metabolites of the dysregulated mevalonate pathway. This evidence concerns the gene HLA-C and neoplasm.